Home / Dermatology
Dermatology
| 3 min read
Burn surgeon presents health economic model projecting burn center will save up to $21 million per year treating patients with the RECELL System
| 2 min read
Galderma announces positive results from Phase 2b study of nemolizumab in patients with moderate-to-severe atopic dermatitis
| 3 min read
PellePharm presents updated data from two Phase 2 studies demonstrating the potential of Patidegib topical gel to treat basal cell carcinomas in patients with Gorlin Syndrome, and in patients with non-Gorlin sporadic BCCs
| 4 min read
Otezla post-hoc sub-analyses showed meaningful improvements in metrics beyond skin clearance
| 2 min read
Clinical trial shows monoclonal antibody drug effective against pruritus
| 3 min read
Patients saw improvements in skin clearing and quality of life
| 2 min read
Soria’s investigational drug provides evidence of actinic keratosis lesion reduction without the local irritation of approved topical AK treatment products
| 4 min read
Kyowa Kirin announces results of Phase 3 clinical study published in Lancet Oncology
| 3 min read
Interim data for key oncology drug candidate MTD201 establishes favorable clinical profile compared to reference product Novartis’ Sandostatin LAR (SLAR)
| 4 min read
Mount Sinai researchers identify networks for developing new therapies to treat Alzheimer’s disease
| 3 min read
USCF team pinpoints how benign moles become cancerous and recreate the process with CRISPR
| 2 min read
Processa Pharmaceuticals receives orphan drug designation for PCS499 in necrobiosis lipoidica from the FDA; will start clinical trials this year
